Eligibility to participate
Team participation in Bionics Queensland Challenge 2020 is encouraged from all walks of life. However, team members will typically be drawn from the categories shown below:
- Hospital, university and private sector professionals: Scientists, clinicians, bio-medical engineers, medtech researchers, technology leaders (e.g., AI, data science, machine learning, AR/VR), additive manufacturing experts and allied health professionals.
- Students: Individuals enrolled in medicine, health, bio-medical engineering or allied programs at Queensland universities or in vocational education and training programs. PhD students at metropolitan and regional universities are strongly encouraged to participate.
- Start-ups, Charities, Small Businesses and Grassroots Innovators: The Bionics Challenge is ideally suited to early-stage business ventures, innovative not-for-profit organisations and spinouts from universities or hospitals engaged in innovation.
- Consumers / end users of bionic devices, technologies, products and services – bionics end users and/or carers or family members who are consulted and engaged throughout the project
- Medtech industry leaders and managers: private sector medtech businesses, product designers, technologists, product development and marketing specialists.
All teams should:
- Link people, science and/or technologies that have not been connected before in shaping their bionic innovation
- Proactively engage bionics end users, their carers or family members in the design and development of new or improved bionic devices, implants, technologies and treatments
- Directly involve an industry partner or team member who is a medtech product designer, assistive technology provider and/or manufacturer in the project to help accelerate product or service development and market entry
- Collaborate with intrastate, inter-state and offshore researchers as appropriate to deliver ‘new to the world’ bionic innovations or improve on existing bionic devices, technologies, treatments and services.
Specific Terms and Conditions
1 – Registration and submission of the Pitch to enter Round 1 must be completed online by the published deadline.
2 – Teams intending to compete for the National Bionics Innovation Prize and/or a Bionics Challenge 2021 Major Category Prize should read all information and requirements of the Challenge on our website before registering and submitting their application to enter Round 1 and uploading their Project Summary.
3 – All entrants should familiarise themselves with the definition of ‘bionics’ provided online and take due care in choosing the Challenge category that best aligns with their project : (1) Bionic Mobility, (2) Bionic Senses, (3) Bionic Implants and Organs, or (4) Bionics, the Brain, Neurotech and AI: Neural and AI-enabled Devices, Brain-Computer-Interfaces, Neurobionic Treatments and Novel Therapies). Note: Bionics Queensland recognises that these categories are not necessarily mutually exclusive, but one category only should be selected.
4 – A minimum of four and a maximum of five team members is expected in each Challenge team. This rule applies to both Queensland-led teams competing for the four Bionics Challenge 2021 Major Category Prizes and to teams competing for the National Bionics Innovation Prize.
Teams from all Australian states and territories are welcome to enter our National Bionics Innovation Prize sponsored by Morgans Financial.
The project should align with one of the four categories of medical bionics innovation outlined in Item 3 above. The national prize may be awarded to a team competing in any one of those categories. The winning team will receive $25,000 in cash from Bionics Queensland to be progressively allocated and expended in line with an agreed project plan and milestones (included in a Deed of Grant signed by Bionics Queensland and the recipient).
The team that wins the National Bionics Innovation Prize must participate in an agreed Bionics Deeptech Mentoring and Acceleration Program delivered by our expert team of medtech advisors and be willing to meet with Morgans Financial personnel to hone their insights on future capital raising.
5 – Teams competing for Bionics Challenge 2021 Major Category Prizes ($50,000 per team plus mentoring and acceleration) and Early-Stage Bionics Innovation Awards ($8,000 per team plus mentoring and acceleration) must be Queensland-led.
For the purposes of this Challenge, a project leader living in Queensland must be nominated and at least two members of the team must be Queensland-based.
Other team members can be drawn from Queensland and/or other states/territories or offshore to optimise the team’s expertise, innovation, industry engagement and collaboration.
6 – All teams must have: a nominated project leader with the remaining team members providing an appropriate mix of researchers, clinicians, engineers, technologists and/or practitioners plus a bionics end user (or patient advocate).
- A potential end user (clinician, patient or consumer as appropriate to your innovation) is a ‘must have’ participant in your team and should be actively involved in your project design and pitch presentation.
- An industry representative is also an important inclusion. This individual may be involved in the research, planning, design, fabrication and/or manufacture of your device, implant, technology or treatment.
- Industry-based mentors, investment advisors or representatives of other accelerators cannot directly participate in Challenge teams and entrants must be exclusively enrolled in Bionics Challenge 2021 and no other multi-week accelerator programs for the duration of the program (mid-July to mid-November 2021).This condition recognises the time commitment and team interaction needed to successfully participate in the Challenge judging and our Bionics Deeptech Mentoring and Acceleration Program.
7 – All Queensland-led team competing in a Bionics Challenge 2021 Major Prize Category can choose to enter the same project in the competition for the National Bionics Innovation Prize.
In this situation, the team should complete two application forms to separately register their participation in their chosen Bionics Challenge 2021 Major Prize Category and the competition for the National Bionics Innovation Prize. Teams taking this path should ensure that their project fulfils the requirements for both contests.
8 – Early-Stage Bionics Innovation Award winners (4 x $8,000 prizes) are selected at the discretion of the judges from teams registered to compete in each of the four Major Prize Categories. Note that the recipients of the Early-Stage Bionics Innovation Awards may or may not be Challenge finalists, with the primary goal of this award being to support early-stage innovators and projects that have the potential to deliver significant impacts in the longer term.
9 – In a situation where an individual researcher/innovator wishes to participate in more than one Challenge team, permission should be formally sought from Bionics Queensland to do so.
10 – Team submissions of all materials and presentations required to progress through each Challenge Round must adhere to related guidelines or criteria for each activity that are progressively shared for the Round 1 Pitch and Grand Challenge judging on this website. A failure to do so could disqualify a team.
11 – All Challenge deadlines required for teams to submit materials or attend events must be met in line with the Terms and Conditions stated on this website. This condition applies to all judging rounds in the Challenge and to the participation of winning teams in our Bionics Deeptech Mentoring and Acceleration Program.
At a minimum the Project Leader must participate in the Bionics Deeptech Mentoring and Acceleration Program and provide relevant input / materials sought. Failure to do so may result in a delayed Deed of Grant for funds dispersal.
12 – The initial Project Summary submitted to organisers should include a project title, the name of the Project Leader, the names of all other participants and content as outlined on the website. You may also wish to include a list of roles and skill sets that each team member brings to the project (e.g., patient or bionics end user or their advocate, project leader, bio-medical engineer, software designer, AI specialist, data analyst, device designer, biofabrication specialist, industry representative or other descriptor).
Note: If the team is not fully formed at the time of application, the project manager should outline proposed actions to attract the additional team member(s) and desired skillsets. If the project is accepted into the Challenge, a complete team (minimum of 4 participants) must exist prior to the Round 1 Pitch event.
13 – The Project Leader of a team must notify the Challenge organiser (Bionics Queensland) of any expected changes or issues that arise with team membership after the closing date for entries. Steps must be taken to maintain a minimum of four participants through to and during the staging of the final judging event. Any changes in team members at any point during the Challenge must be approved by Bionics Queensland.
14 – Upon registration, all teams agree that (a) the project leader and team members are willing to participate in events leading up and during the Round 1 Pitch and final judging, and (b) all team members will make themselves available to participate in judging i.e., the Round 1 pitch and final judging event.
Note: All Bionics Challenge ‘21 events, judging rounds and mentoring programs will be delivered in virtual format. Challenge finalists will be offered guidance on final preparation of project plans and slide decks plus video production support services to enable them to successfully prepare their video pitch for the final judging event.
15 – Upon registration, all teams should have taken early steps to identify any existing intellectual property (IP) owned by team members, other individuals or organisations. Project leaders should confirm that any IP included in their public presentations or written submissions is adequately protected.
The respective Technology Transfer Offices or Research Offices in organisations linked to the project should be contacted. Note that Bionics Qld has an engagement with project leaders, team members and relevant commercialisation personnel in shaping winners’ contracts and related milestones for funds (prize) distribution.
Any data or information discussed or divulged in public sessions by entrants should be considered information that could enter the public realm, and entrants should not assume any right of confidentiality in data or information divulged in these sessions. Due to the nature of this Challenge, our judges, reviewers, staff or the audience are not obligated and will not be asked to sign non-disclosure statements (NDAs). If a team uses copyrighted materials and/or images from a third party in their submissions or presentations, they must obtain permission in advance and identify the source.
16 – If selected as a Bionics Challenge ’21 prize winner, the project leader and/or IP owner will sign a Deed of Grant with Bionics Queensland that includes:
- Details of how the cash prize will be exclusively used for project expenses aligned to milestone activities and achievements.
- A Challenge funds dispersal timeframe. Funds will be paid on invoice; issued to an ABN, not a person; and must be used to conduct further activities (e.g., industrial design, research, development and/or testing of the innovation) as defined in the Deed of Grant.
- The agreed schedule and timeframe for the team to report to and engage with Bionics Queensland on the progress of the project, the expenditure of funds, and the team and/or IP owners’ pathway towards commercialisation.
17 – It is expected that all teams who enter the Challenge will have further research and engagement (e.g., end users, patients or key opinion leaders), clinical testing and prototype development to be undertaken and the Challenge prize will help to achieve related milestones. Note: Team members are responsible for all tax implications that might arise as a result of accepting cash payments from Bionics Queensland.
18 – All teams are required to participate in media and press opportunities related to the Challenge, including media interviews and statements released to the media in oral and written form. This publicity could occur at any time throughout the Challenge and could feature representatives of Bionics Queensland, the Motor Accident Insurance Commission of Queensland, the Queensland Government and representatives of sponsoring organisations (e.g., Morgans Financial or others) alongside team members.
All Challenge team members sign a waiver allowing Bionics Queensland the right to photograph and film their participation during the Challenge events and post-judging publicity campaign for marketing purposes. Participation in media and press opportunities does not require teams to disclose any proprietary or otherwise confidential information related to their business or product concepts.
Bionics Challenge 2021
Bionics Challenge 2021, delivered in partnership with the Motor Accident Insurance Commission (Qld) has provided over $300k in combined Cash Prizes, Mentoring and Acceleration.
Motor Accident Insurance Commission
The Motor Accident Insurance Commission (MAIC) Queensland is our major funding partner. The rehabilitation of Queenslanders impacted by road accident trauma, disabilities and chronic health conditions underpins our highly valued partnership.